Massachusetts Financial Services
STOK icon

Massachusetts Financial Services’s Stoke Therapeutics STOK Stock Holding History

Massachusetts Financial Services’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Sell
10,829
-11,816
-52% -$379K ﹤0.01% 972
2026
Q1 		$737K Buy
22,645
+3,544
+19% +$116K ﹤0.01% 864
2025
Q4 		$606K Buy
+19,101
New +$574K ﹤0.01% 856

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services's STOK Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Stoke Therapeutics (STOK) stake by 52% in Q2 2026, selling an estimated $379K and leaving 10,829 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Massachusetts Financial Services first reported a position in STOK in Q4 2025 and has held it in 3 quarters since. The position peaked at $737K in Q1 2026. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Massachusetts Financial Services held 10,829 shares of Stoke Therapeutics worth $354K as of Q2 2026.
  • Massachusetts Financial Services sold 11,816 Stoke Therapeutics shares in Q2 2026, an estimated $379K.
  • Stoke Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #972 holding.
  • Massachusetts Financial Services first reported a position in Stoke Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Massachusetts Financial Services's Stoke Therapeutics position peaked at $737K in Q1 2026.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.